DRTSW - Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn M.D. Appointed to Alpha Tau Advisory Board | Benzinga
JERUSALEM, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Stephen M. Hahn, M.D., former commissioner of the U.S. Food and Drug Administration ("FDA"), has joined its Scientific Advisory Board. A distinguished expert in the field of radiation oncology and translational/clinical research, and a renowned physician, Dr. Hahn brings a wealth of regulatory and scientific experience to the Company as it advances its Alpha DaRT technology towards FDA clearance.
"I am pleased to welcome Dr. Hahn to the Alpha Tau Scientific Advisory Board at an ideal time in the Company's growth trajectory," said Company CEO Uzi Sofer. "As we continue to focus on executing our clinical strategy, including with our ongoing multicenter ReSTART pivotal trial for recurrent Squamous Cell Carcinoma of the skin, and on broadening the Alpha DaRT treatment to other indications such as pancreatic, head and neck, and prostate cancers and glioblastoma, which the Company is already exploring in clinical trials in earnest, Dr. Hahn's vast expertise and insight will be of tremendous value. We are very excited by what this wonderful partnership can potentially offer cancer patients worldwide."
Dr. Hahn is currently CEO-Partner of Flagship Pioneering and CEO of Harbinger Health, where he specializes in innovating in the field of preventive health care and global health strategy. He previously served as FDA Commissioner from 2019 to 2021, overseeing regulatory affairs, including therapeutics and vaccine development, devices, diagnostics, and clinical trials. Prior to his FDA appointment, Dr. Hahn served as chief medical executive, deputy president, and chief operating officer at the world renowned MD Anderson Cancer Center in Houston, Texas. Prior to his executive leadership ...